title: [The growth and morphological characteristics of undifferentiated and differentiated cells of the F9 mouse teratocarcinoma line].
abstract: Differentiation of the F9 cell line was induced by treating the cells with retinoic acid (10(-6) M) and dibutyryl cycloadenosinemonophosphate (10(-4) M). The population doubling time and the portion of cells in G1-phase increase and saturation density falls as the result of this treatment. Differentiated F9 cells demonstrate a decreased capacity of forming colonies in the soft agar, lose their capacity of proliferating at the clonal density, and acquire the limited life-span in culture after reseeding at a high density. Some cells in the differentiated population retain their capacity of forming colonies in the soft agar and (or) of binding antibodies against the stem cell marker SSEA-1. Cells with the stem cell morphology were found in the course of passaging of differentiated cells after reseeding at a high density. These cells were able to differentiate after the standard procedure of the induction of differentiation with retinoic acid and dibutyryl cAMP. Causes of the rising and supporting of heterogeneity of the differentiated F9 cells are discussed.
authors.forename: T V
authors.initials: TV
authors.lastname: Kisliakova
authors.forename: T V
authors.initials: TV
authors.lastname: Pospelova
authors.forename: V A
authors.initials: VA
authors.lastname: Pospelov
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000032:analysis; D000951:Antigens, Neoplasm / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D014408:Biomarkers, Tumor / Q000276:immunology; D003994:Bucladesine / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000473:pathology*; D006017:Glycolipids / Q000276:immunology; D016256:Lewis X Antigen; D051379:Mice; D010641:Phenotype; D013724:Teratoma / Q000473:pathology*; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D014408:Biomarkers, Tumor; D006017:Glycolipids; D016256:Lewis X Antigen; D014212:Tretinoin; D003994:Bucladesine